Physician profile
George Russell Huffman
NPI 1699703157
$253,295.86
in general payments reported to CMS, 2019-2025
29 companies · $91K in 2025
The $91K reported for 2025 was more than what 97% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20K · 2020: $6,675 · 2021: $18K · 2022: $27K · 2023: $46K · 2024: $45K · 2025: $91K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $85K · Consulting Fee: $74K · Travel and Lodging: $18K · Food and Beverage: $4,124 · Long Term Medical Supply Or Device Loan: $87.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $85,115.55 |
| Consulting Fee | $74,237.50 |
| Travel and Lodging | $17,833.64 |
| Food and Beverage | $4,123.95 |
| Long Term Medical Supply Or Device Loan | $87.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $149,997.19 | 2021-2025 | Arthrex |
| Lima USA, INC. | $57,573.25 | 2019-2023 | Tema Elbow, Smr Shoulder |
| Limacorporate S.P.A. | $27,415.42 | 2019-2024 | Tema Elbow, Promade, Tema Elbow |
| Reel Surgical, INC. | $10,902.84 | 2022-2025 | |
| Encore Medical, Lp | $3,970.89 | 2019-2025 | Djo Surgical |
| Liberty Surgical INC. | $795.79 | 2020-2021 | |
| Tigon Medical LLC | $558.20 | 2024 | |
| Stryker Corporation | $458.22 | 2021-2025 | Blueprint Patient Specific Instrumentation, Tornier Perform Anatomic Augmented Glenoid |
| Dynasplint Systems INC. | $364.03 | 2021 | |
| Fx Shoulder Solutions, INC | $327.68 | 2019 | |
| Linvatec Corporation | $143.17 | 2019-2021 | |
| Acumed LLC | $120.16 | 2021-2022 | |
| Shoulder Innovations, INC. | $91.93 | 2024 | Inset System |
| Integra Lifesciences Corporation | $87.45 | 2025 | Micromatrix |
| Smith+Nephew, INC. | $84.80 | 2020-2025 | Firstpass, Na |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exactech, INC. | $81.14 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $60.91 | 2023-2025 | Exparel, Iovera, Zilretta |
| Ferring Pharmaceuticals INC. | $45.47 | 2022-2023 | Euflexxa |
| Convatec INC. | $43.45 | 2022-2024 | |
| Embody, INC. | $31.73 | 2022 | |
| Bioventus LLC | $24.09 | 2023 | Gelsyn-3 |
| Innovation Technologies INC | $23.00 | 2022 | |
| Globus Medical, INC. | $21.30 | 2024 | Proximal Humerus Strut |
| Heron Therapeutics, INC. | $18.92 | 2024 | Zynrelef |
| Depuy Synthes Sales INC. | $15.71 | 2022 | |
| Restor3d, INC. | $14.49 | 2025 | |
| Anika Therapeutics, INC. | $12.94 | 2022 | |
| Ermi LLC | $11.69 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$196,340.93 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Russell Huffman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.